512600 ASTALLTD

Astal Laboratories Share Price

₹94.00 -1.9 (-1.98%)

21 Nov, 2024 17:20

SIP TrendupStart SIP in ASTALLTD

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 3.92%
  • Over 3 Month -4.17%
  • Over 6 Month + 119.01%
  • Over 1 Year + 166.06%
SIP Lightning

Smart Investing Starts Here Start SIP with Astal Laboratories for Steady Growth!

Invest Now

Astal Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Astal Laboratories Financials

Astal Laboratories Technicals

EMA & SMA

Current Price
₹94.00
-1.9 (-1.98%)
pointer
  • stock-down_img
  • Bullish Moving Average 8
  • stock-up_img
  • Bearish Moving Average 8
  • 20 Day
  • ₹94.63
  • 50 Day
  • ₹96.48
  • 100 Day
  • ₹88.71
  • 200 Day
  • ₹70.86

Resistance and Support

95.9 Pivot Speed
  • R3 95.90
  • R2 95.90
  • R1 95.90
  • S1 95.90
  • S2 95.90
  • S3 95.90

What's your outlook on Astal Laboratories?

You can only vote for once

Astal Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-07-27 Quarterly Results
2024-07-06 To consider issue of Warrants & A.G.M. (Revised)
2024-05-24 Audited Results
2024-02-09 Quarterly Results

Astal Laboratories F&O

Astal Laboratories Shareholding Pattern

No data available.

About Astal Laboratories

  • NSE Symbol
  • ASTALLTD
  • BSE Symbol
  • 512600
  • ISIN
  • INE307N01014

Similar Stocks to Astal Laboratories

Astal Laboratories FAQs

Astal Laboratories share price is ₹94 As on 21 November, 2024 | 17:06

The Market Cap of Astal Laboratories is ₹46.3 Cr As on 21 November, 2024 | 17:06

The P/E ratio of Astal Laboratories is 9.8 As on 21 November, 2024 | 17:06

The PB ratio of Astal Laboratories is 2 As on 21 November, 2024 | 17:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23